Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection

Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection

IntroductionTranscutaneous immunization (TCI) is a non-invasive vaccination method promoting strong cellular immune responses, crucial for the immunological rejection of cancer. Previously, we reported on the combined application of the TLR7 agonist imiquimod (IMQ) together with the anti-psoriatic d...

Full description

Bibliographic Details
Main Authors:	Ann-Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, Sophie Luise Meiser, Danielle Arnold-Schild, Matthias Klein, Michael Stassen, Hansjörg Schild, Sabine Muth, Hans Christian Probst, Peter Langguth, Stephan Grabbe, Markus P. Radsak
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Immunology
Subjects:	trancutaneous immunization imiquimod (IMQ) dithranol (anthralin) cytotoxic T lymphocytes (CTL) tumor rejection
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1238861/full

Similar Items

Dithranol as novel co-adjuvant for non-invasive dermal vaccination
by: Julian Sohl, et al.
Published: (2022-09-01)

Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccination
by: Julian Sohl, et al.
Published: (2023-06-01)

Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis
by: Theresa Benezeder, et al.
Published: (2020-06-01)

Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy
by: Joschka Bartneck, et al.
Published: (2023-10-01)

Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulation.
by: Pamela Stein, et al.
Published: (2014-01-01)

Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization.
by: Pamela Stein, et al.
Published: (2011-01-01)

Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product
by: Jonas Pielenhofer, et al.
Published: (2023-02-01)

Comparative assessment of topical steroids, topical tretenoin (0.05%) and dithranol paste in alopecia areata
by: Das Sudip, et al.
Published: (2010-01-01)

“Pigmented irritant contact dermatitis” − an issue of concern due to dithranol misuse in Andaman and Nicobar: an observational study
by: Pradeep Balasubramanian, et al.
Published: (2020-01-01)

Soluble Triggering Receptor Expressed on Myeloid Cells 1 Is Released in Patients with Stable Chronic Obstructive Pulmonary Disease
by: Markus P. Radsak, et al.
Published: (2007-01-01)

Electrospun PCL/PVA Coaxial Nanofibers with Embedded Titanium Dioxide and Magnetic Nanoparticles for Stabilization and Controlled Release of Dithranol for Therapy of Psoriasis
by: Natália Andrýsková, et al.
Published: (2023-07-01)

Microneedle-enhanced drug delivery: fabrication, characterization, and insights into release and permeation of nanocrystalline imiquimod
by: Sophie Luise Meiser, et al.
Published: (2024-06-01)

The Effect of Szigetvár Medicinal Water on HaCaT Cells Exposed to Dithranol
by: István Szabó, et al.
Published: (2024-10-01)

A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.
by: Gerd Gladigau, et al.
Published: (2012-01-01)

Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery
by: Jonas Pielenhofer, et al.
Published: (2020-02-01)

Computational Design of a Novel Dithranol–Salicylic Acid Antipsoriatic Prodrug for Esterase-Activated Topical Drug Delivery
by: Natália Andrýsková, et al.
Published: (2024-01-01)

Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease.
by: Michael Weber, et al.
Published: (2013-01-01)

Author Correction: ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis
by: Astrid Alflen, et al.
Published: (2018-09-01)

ERK3/MAPK6 controls IL-8 production and chemotaxis
by: Katarzyna Bogucka, et al.
Published: (2020-04-01)

Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapy
by: Hakim Echchannaoui, et al.
Published: (2024-07-01)

Statistical optimization of dithranol-loaded solid lipid nanoparticles using factorial design
by: Makarand Suresh Gambhire, et al.
Published: (2011-09-01)

The Hsc/Hsp70 co-chaperone network controls antigen aggregation and presentation during maturation of professional antigen presenting cells.
by: Nadja Kettern, et al.
Published: (2011-01-01)

A trifunctional dextran-based nanovaccine targets and activates murine dendritic cells, and induces potent cellular and humoral immune responses in vivo.
by: Limei Shen, et al.
Published: (2013-01-01)

Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients
by: Dina Fathalla, et al.
Published: (2020-05-01)

Neutrophil-Specific Knockdown of β2 Integrins Impairs Antifungal Effector Functions and Aggravates the Course of Invasive Pulmonal Aspergillosis
by: Maximilian Haist, et al.
Published: (2022-06-01)

Polyethylene Glycol Ointment Alleviates Psoriasis-Like Inflammation Through Down-Regulating the Function of Th17 Cells and MDSCs
by: Yan Lu, et al.
Published: (2021-03-01)

Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis
by: Alex W. White, et al.
Published: (2013-04-01)

Chloramphenicol Acetyltransferase Expression as a Sensor for Fusion Activity
by: Dorothee Gicklhorn, et al.
Published: (1999-11-01)

From Plant to Patient: A Historical Perspective and Review of Selected Medicinal Plants in Dermatology
by: Aygun Israyilova, et al.
Published: (2025-01-01)

IQM of a tourism destination as a tool of competitiveness
by: Ida Vajčnerová
Published: (2011-01-01)

TAZ deficiency exacerbates psoriatic pathogenesis by increasing the histamine-releasing factor
by: Jiseo Song, et al.
Published: (2024-05-01)

Due semantiche del 'vedere' ne I giorni e gli anni di Uwe Johnson
by: Sabine Schild-Vitale
Published: (2015-01-01)

Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide/Phospholipid Composite Cerosomes Co-Delivery of Cyclosporine and Dithranol: In-Vitro, Ex-Vivo, and in-Vivo Studies
by: Elhabal SF, et al.
Published: (2024-02-01)

Essential Oil of Matricaria chamomilla Alleviate Psoriatic-Like Skin Inflammation by Inhibiting PI3K/Akt/mTOR and p38MAPK Signaling Pathway
by: Chen G, et al.
Published: (2024-01-01)

Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice
by: Amparo Martínez-Pérez, et al.
Published: (2023-04-01)

ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression
by: Kristina Riegel, et al.
Published: (2021-10-01)

Cellular Immune Dysfunction in Obstructive Sleep Apnea
by: Katharina Ludwig, et al.
Published: (2022-07-01)

Synthesis and Spectroscopic Characterization of a Series of New Anthralin Derivatives and Their Corresponding Spiro-Hetherocycles
by: Jabbar Khalafy, et al.
Published: (1990-06-01)

Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase
by: Ao Hu, et al.
Published: (2020-02-01)

Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels
by: Maximilian Scherger, et al.
Published: (2020-10-01)